Differentiation induction in non-lymphocytic leukemia cells upon treatment with mizoribine

International Journal of Hematology

Volumn 66, Issue 3, 1997, Pages 335-344

  Inai, Kunihiro ^a   Tsutani, Hiroshi ^a   Yamauchi, Takahiro ^a   Huberman, Eliezer ^b   Nakamura, Toru ^a   Ueda, Takanori ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

Acute nonlymphocytic leukemia; Differentiation induction; IMP dehydrogenase; Intracellular GTP level; Mizoribine

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; INOSINE PHOSPHATE; MIZORIBINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; MALE; PRIORITY JOURNAL;

EID: 0031258330     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00044-3     Document Type: Article

References (28)

1. Jackson R.C., Weber G. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature. 256:1975;331-333.
2. Collart F.R., Huberman E. Cloning and sequence analysis of the human and Chinese hamster inosine-5′-monophosphate dehydrogenase cDNAs. J Biol Chem. 263:1988;15769-15772.
3. Natsumeda Y., Ohno S., Kawasaki Y., Konno Y., Weber G., Suzuki K. Two distinct cDNAs for human IMP dehydrogenase. J Biol Chem. 265:1990;5292-5995.
4. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes memorial lecture. Cancer Res. 43:1983;3466-3492.
5. Balzarini J., Lee C.K., Herdewijn P., Clercq E.D. Mechanism of the potentiating effect ribavirin on the activity of 2′,3′-dideoxyinosine against human immunodeficiency virus. J Biol Chem. 266:1991;21509-21514.
6. Goldsmith M.F. Researchers follow varied molecular paths toward better control of organ rejection. J Am Med Assoc. 263:1990;1184-1187.
7. Sidi Y., Panet C., Wasserman L., Cyjon A., Novogrodsky A., Nordenberg J. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor. Br J Cancer. 58:1988;61-63.
8. Nagai M., Natsumeda Y., Weber G. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 cells. Cancer Res. 52:1992;258-261.
9. Konno Y., Natsumeda Y., Nagai M., Yamaji Y., Ohno S., Suzuki K., Weber G. Expression of human IMP dehydrogenase type I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J Biol Chem. 266:1991;506-509.
10. Nagai M., Natsumeda Y., Konno Y., Hoffman R., Irino S., Weber G. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res. 51:1991;3886-3890.
11. Sakaguchi K., Tsujino M., Yoshizawa M., Mizuno K., Hayano K. Action of bredinin on mammalian cells. Cancer Res. 35:1975;1643-1648.
12. Turk L.A., Dayton J., Sinclair G., Thompson C.B., Mitchell B.S. Guanine ribonucleotide depletion inhibits T cell activation. J Clin Invest. 87:1991;940-948.
13. Tsutani H., Sugiyama T., Shimizu S., Iwasaki H., Ueda T., Ozaki K., Konda S., Nakamura T. Discordance LFA-1/ICAM-1 expression in a case of secondary plasma cell leukemia associated with subcutaneous plasmacytoma. Am J Hematol. 42:1993;299-304.
14. Collins S.J., Bodner A., Ting R., Gallo R.C. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells. Int J Cancer. 25:1980;213-218.
15. Yamauchi T., Ueda T., Nakamura T. A new sensitive method for determination of intracellular 1-β-D-arabinofuranosylcytosine 5′-triphosphate content in human materials in vivo. Cancer Res. 56:1996;1800-1804.
16. Collart F.R., Huberman E. Amplification of the IMP dehydrogenase gene in Chinese hamster cells resistant to mycophenolic acid. Mol Cell Biol. 7:1987;3328-3331.
17. Sokoloski J.A., Blair O.C., Sartorelli A.C. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase. Cancer Res. 46:1986;2314-2319.
18. Lucus D.C., Webster H.K., Wright D.G. Purine metabolism in myeloid precursor cells during maturation. J Clin Invest. 72:1983;1889-1900.
19. Kiguchi K., Collart F.R., Chubb H.C., Huberman E. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: Altered patterns of IMP dehydrogenase expression and activity. Cell Growth Differ. 1:1990;259-270.
20. Kiguchi K., Collart F.R., Chubb H.C., Huberman E. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphocytoid leukemia cells by mycophenolic acid and tiazofurin. Exp Cell Res. 187:1990;47-53.
21. Olah E., Natsumeda Y., Ikegami T., Kote Z., Horanyi M., Szelenyi J., Paulik E., Kremmer T., Hollan S.K., Sugar J., Weber G. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells. Proc Natl Acad Sci USA. 85:1988;6533-6537.
22. Collart F.R., Huberman E. Expression of IMP dehydrogenase in differentiating HL-60 cells. Blood. 75:1990;570-576.
23. Takada K., Nakae H., Asada S., Ichikawa Y., Fukunishi T., Sonoda T. Rapid method for the high-performance liquid chromatographic determination of bredinin in human serum. J Chromatogr. 222:1981;156-159.
24. Huang M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhoa L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
25. Castaigne S., Chomienne C., Daniel M.T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76:1990;1704-1709.
26. Tricot G.J., Jayaram H.N., Lapis E., Natsumeda Y., Nichols C.R., Kneebone P., Heerema N., Weber G., Hoffman R. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity. Cancer Res. 49:1989;3696-3701.
27. Weber G., Nakamura Y., Natsumeda Y., Szekeres T., Nagai M. Regulation of GTP biosynthesis. Adv Enzyme Regul. 32:1992;57-69.
28. Natsumeda Y., Ikegami T., Olah E., Weber G. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells. Cancer Res. 49:1989;88-92.